| European Case Law Identifier: | ECLI:EP:BA:2000:T107197.20000817 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 17 August 2000 | ||||||||
| Case number: | T 1071/97 | ||||||||
| Application number: | 90305744.6 | ||||||||
| IPC class: | A61K 9/107 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Adjuvant formulation comprising a submicron oil droplet emulsion | ||||||||
| Applicant name: | CHIRON CORPORATION | ||||||||
| Opponent name: | SmithKline Beecham Biologicals SA Akzo Nobel N.V. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Third and fourth auxiliary requests: admissibility (no), late-filed, fresh cases; first auxiliary request: allowability (no): disclaimer contravenes Article 123(2) EPC Main and second auxiliary requests: novelty (yes): subject-matter of the claims not directly and unambiguously derivable from the cited state of the art; inventive step (no): replacement of the emulsifying agent in the closest vaccines by different known emulsifying agents obvious; sufficiency (yes): the same level of skill has to be applied to the question of inventive step and sufficiency of disclosure, no evidence provided to support allegation of insufficiency |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t971071eu1.html
Date retrieved: 17 May 2021